Clarifying immunotherapy

  • Letters Premium
  • Friday, 03 Mar 2017

WE read with great interest the article “A case for immunotherapy” (Sunday Star, Feb 12). Firstly, we would like to congratulate Chin (nasopharyngeal cancer) and Wong (prostate cancer) on improvements in their condition and for their successful struggle against cancer. Many like these two men are increasingly facing up to the reality of a cancer diagnosis as its prevalence rises in the Asia-Pacific region. However, upon reading the article we also noted several disturbing points regarding their treatment which we would like to highlight here.

Firstly, immunotherapy is indeed emerging as a new and exciting breakthrough in our treatment armamentarium against cancer. Immunotherapy aims to harness or enhance the ability of our own immune system to recognise and mount an immune response against cancer cells. Indeed, over the past few years, several immune therapies such as PD-1 and PDL-1 checkpoint inhibitors have now received licensing approval from major health authorities such as the US Federal Drug Agency (FDA) and European Medicines Agency (EMA). Much time, cost and effort have gone into performing clinical trials involving thousands of patients in order to prove that these treatments are superior to current available treatments and can be safely given with acceptable side effects. Not least as these treatments are usually very costly, we need to be sure that they work before they are offered to the public.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Opinion , immunotherapy


Next In Letters

Facing up to new variant Premium
Imposing another lockdown must be the last option Premium
Importance of accepting the One China policy Premium
Vaccination booster shot necessary, Health Ministry should review hasty notification Premium
Strategies to combat high food inflation Premium
Govt's firmness and seriousness in handling Omicron variant a relief to the Malaysian Family Premium
#MeToo: Proving sexual harassment Premium
High prices could escalate food insecurity Premium
The postman didn’t ring twice, letters not delivered Premium
Still awaiting digital cert after four months Premium

Others Also Read